World J Mens Health.  2023 Jan;41(1):14-48. 10.5534/wjmh.220067.

Impact of Antioxidant Therapy on Natural Pregnancy Outcomes and Semen Parameters in Infertile Men: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Affiliations
  • 1American Center for Reproductive Medicine, Global Andrology Forum, Moreland Hills, OH, USA
  • 2Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
  • 3Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
  • 4Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University, Sohag, Egypt
  • 5Ajyal IVF Center, Ajyal Hospital, Sohag, Egypt
  • 6Department of Urology, Mansoura University Urology and Nephrology Center, Mansoura, Egypt
  • 7Department of Surgery, Urology Unit, Farwaniya Hospital, Farwaniya, Kuwait
  • 8Department of Urology, Sabah Al Ahmad Urology Center, Kuwait City, Kuwait
  • 9Fakih IVF Fertility Center, Abu Dhabi, UAE
  • 10Department of Endocrinology, Polytechnic University of Marche, Ancona, Italy
  • 11Reproductive Biology, Fertility Preservation, Andrology, CECOS, Poissy Hospital, Poissy, France
  • 12Department of Biology, Reproduction, Epigenetics, Environment and Development, Pari. Saclay University, UVSQ, INRAE, BREED, Jouy-en-Josas, France
  • 13Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA
  • 14Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada
  • 15Next Fertility Procrea, Lugano, Switzerland
  • 16Department of Urology, Selcuk University School of Medicine, Konya, Turkey
  • 17Austin Fertility & Reproductive Medicine/Westlake IVF, Austin, TX, USA
  • 18Department of Urology, King Abdulaziz University, Jeddah, Saudi Arabia
  • 19Department of Urology, Faculty of Medicine, Minia University, Minia, Egypt
  • 20Department of Urology, Loma Linda University Health, Loma Linda, CA, USA
  • 21Department of Urology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey
  • 22Department of Urology, Fatih Sultan Mehmet Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
  • 23Department of Urology, Medical University Innsbruck, Innsbruck, Austria
  • 24Department of Urology, Pusan National University School of Medicine, Busan, Korea
  • 25Medical Research Institute of Pusan National University Hospital, Busan, Korea
  • 26Urology Institute, University Hospitals, Case Western Reserve University, Cleveland, OH, USA
  • 27Division of Surgery, Department of Surgery and Cancer, Imperial College, London, UK
  • 28Department of Urology and Organ Transplantation, University of Foggia, Ospedali Riuniti of Foggia, Foggia, Italy
  • 29SENSART Clinic, Istanbul, Turkey
  • 30Section of Andrology, Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • 31Department of Urology, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia
  • 32Urology Section, University of Catania, Catania, Italy
  • 33Department of Urology, Centro Universitario em Saude do ABC, Santo André, Brazil
  • 34Andrology Group at Ideia Fertil Institute of Human Reproduction, Santo André, Brazil
  • 35Department of Reproductive Endocrinology and Andrology, Imperial College London, London, UK
  • 36Department of Andrology, Hammersmith & St. Mary’s Hospitals, London, UK
  • 37Division of Andrology, Department of Urology, Lilavati Hospital and Research Centre, Mumbai, India

Abstract

Purpose
Seminal oxidative stress (OS) is a recognized factor potentially associated with male infertility, but the efficacy of antioxidant (AOX) therapy is controversial and there is no consensus on its utility. Primary outcomes of this study were to investigate the effect of AOX on spontaneous clinical pregnancy, live birth and miscarriage rates in male infertile patients. Secondary outcomes were conventional semen parameters, sperm DNA fragmentation (SDF) and seminal OS.
Materials and Methods
Literature search was performed using Scopus, PubMed, Ovid, Embase, and Cochrane databases. Only randomized controlled trials (RCTs) were included and the meta-analysis was conducted according to PRISMA guidelines.
Results
We assessed for eligibility 1,307 abstracts, and 45 RCTs were finally included, for a total of 4,332 infertile patients. We found a significantly higher pregnancy rate in patients treated with AOX compared to placebo-treated or untreated controls, without significant inter-study heterogeneity. No effects on live-birth or miscarriage rates were observed in four studies. A significantly higher sperm concentration, sperm progressive motility, sperm total motility, and normal sperm morphology was found in patients compared to controls. We found no effect on SDF in analysis of three eligible studies. Seminal levels of total antioxidant capacity were significantly higher, while seminal malondialdehyde acid was significantly lower in patients than controls. These results did not change after exclusion of studies performed following varicocele repair.
Conclusions
The present analysis upgrades the level of evidence favoring a recommendation for using AOX in male infertility to improve the spontaneous pregnancy rate and the conventional sperm parameters. The failure to demonstrate an increase in live-birth rate, despite an increase in pregnancy rates, is due to the very few RCTs specifically assessing the impact of AOX on live-birth rate. Therefore, further RCTs assessing the impact of AOX on live-birth rate and miscarriage rate, and SDF will be helpful.

Keyword

Antioxidants; Male infertility; Meta-analysis; Pregnancy; Semen parameters; Sperm DNA fragmentation
Full Text Links
  • WJMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr